| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.5 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.034 | 0.5 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.5 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.5 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | -0.11 | 0.5 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | 0.026 | 0.5 |